EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice

Jie Gao, Shumei Ren, Gabrielle Choonoo iD, Guoying Chen, Davor Frleta, Jun Zhong, Namita Gupta iD, Prachi Sharma, Adelekan Oyejide, Gurinder S Atwal iD, Lynn Macdonald, Andrew Murphy und 1 weitere

Disease Models & Mechanisms · 2023

DOI: 10.1242/dmm.050190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2023. Verfasst von Jie Gao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA. Hauptthemen laut MEDLINE: Skin Neoplasms, Lymphoma, T-Cell, Cutaneous, Sezary Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regeneron Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sezary syndrome (SS) is a rare, aggressive leukemic variant of cutaneous T-cell lymphoma (CTCL) that lacks adequate therapeutic options and representative small-animal models. Here, we demonstrate that IL-15 is a critical CTCL growth factor. Importantly, an immunodeficient knock-in mouse model genetically engineered to express human IL-15 uniquely supported the growth of SS patient samples relative to conventional immunodeficient mouse strains. SS patient-derived xenograft (PDX) models recapacitated key pathological features of the human disease, including skin infiltration and spread of leukemic cells to the periphery, and maintained the dependence on human IL-15 upon serial in vivo passaging. Detailed molecular characterization of the engrafted cells by single-cell transcriptomic analysis revealed congruent neoplastic gene expression signatures but distinct clonal engraftment patterns. Overall, we document an important dependence of Sezary cell survival and proliferation on IL-15 signaling and the utility of immunodeficient humanized IL-15 mice as hosts for SS – and potentially other T and NK cell-derived hematologic malignancies – PDX model generation. Furthermore, these studies advocate the thorough molecular understanding of the resultant PDX models to maximize their translational impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsLymphoma, T-Cell, CutaneousSezary SyndromeHumansAnimalsMiceInterleukin-15LymphocytesTumor Microenvironment

Stichwörter der Autor:innen

CTCLHumanized miceIL-15PDXSezary syndrome

Substanzen

Interleukin-15

Autor:innen und Institutionen

  • Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.

ORCID-Profile: Gabrielle Choonoo, Namita Gupta, Gurinder S Atwal, Frank Kuhnert

Förderung

  • Regeneron Pharmaceuticals

Zitieren

APA

Gao, J., Ren, S., Choonoo, G., Chen, G., Frleta, D., Zhong, J., Gupta, N., Sharma, P., Oyejide, A., Atwal, G. S., Macdonald, L., Murphy, A., & Kuhnert, F. (2023). Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.050190

Vancouver

Gao J, Ren S, Choonoo G, Chen G, Frleta D, Zhong J, et al. Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice. Disease Models & Mechanisms. 2023. doi:10.1242/dmm.050190

BibTeX
@article{Gao2023,
  author = {Gao, Jie and Ren, Shumei and Choonoo, Gabrielle and Chen, Guoying and Frleta, Davor and Zhong, Jun and Gupta, Namita and Sharma, Prachi and Oyejide, Adelekan and Atwal, Gurinder S and Macdonald, Lynn and Murphy, Andrew and Kuhnert, Frank},
  title = {Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice},
  journal = {Disease Models & Mechanisms},
  year = {2023},
  doi = {10.1242/dmm.050190}
}
Kostenlos starten →